Celldex Therapeutics | CLDX - Pasivo Circulante

Precio De Mercado
33.42
Cambio Diario
1.01 3.12%
Mensual
7.29%
Anual
109.66%
Q2 Expectativa
30.13




Pasivo Circulante Cambio Fecha
AbbVie USD 43.29B 3.9B 2025-12
Agenus USD 323.49M 36.36M 2025-12
Amgen USD 25.49B 3.7B 2025-12
Bristol-Myers Squibb USD 28.14B 608M 2025-09
Celldex Therapeutics USD 50.99M 4.53M 2025-12
Glaxosmithkline GBP 28.82B 144.79M 2025-12
Nektar Therapeutics USD 53.54M 12.8M 2025-12
Northwest Biotherapeutics USD 87.9M 3.98M 2025-09
Pfizer USD 36.6B 1.13B 2025-09
Rigel Pharmaceuticals USD 94.4M 7.76M 2025-09
Roche Holding CHF 28B 421M 2025-12